Please provide your email address to receive an email when new articles are posted on . The approval was based on results from two phase 3 randomized, double-blind, multicenter trials, CAMP-1 and CAMP ...
Verrica Pharmaceuticals’ lead candidate, a drug-device combination for dermatology indications, hit its primary endpoints in two phase 3 trials testing it in the skin infection molluscum contagiosum.
Topical cantharidin (Ycanth) was approved as the first treatment specifically for molluscum contagiosum, the FDA announced. Molluscum contagiosum is a viral skin infection that affects as many as 6 ...
(RTTNews) - Verrica Pharmaceuticals Inc. (VRCA), Friday announced U.S. Food and Drug Administration (FDA) approval of Ycanth (cantharidin) topical solution for the treatment of molluscum contagiosum ...
Patients with molluscum contagiosum treated with topical berdazimer gel had positive efficacy rates, according to a phase 3 clinical trial. “Currently, there are no FDA-approved medications for ...
– SB206, if approved, has the potential to meet an important need for the treatment of molluscum, an area with no current FDA-approved treatment – B-SIMPLE4 is a multi-center, double-blind, randomized ...
Despite sounding like a Harry Potter spell, Molluscum Contagiosum is neither as well-known nor as whimsical as its name may suggest. Most people know about high-profile sexually transmitted infections ...
– Molluscum, is a highly contagious viral skin infection affecting approximately 6 million people annually in the United States, primarily children – – YCANTH™ is a drug-device combination product ...
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Novan, Inc. (Nasdaq: NOVN) has submitted a New Drug Application (NDA) to the U.S. Food and ...
While generally harmless, Molluscum is a very common skin condition amongst children ages 2-10. So common that you may know them by their nickname "Water Warts" instead! In today's episode, Skincast ...
The anticipated US Food and Drug Administration (FDA) approval of VP-102 for the treatment of molluscum contagiosum has been delayed because of deficiencies identified at a contract manufacturing ...
The Food and Drug Administration is warning against self-diagnosis and self-treatment for a common skin condition - a viral infection often called "water warts." One mother from Tustin said they went ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback